Discover how miR-495, a tiny molecule, regulates estrogen and progesterone receptors in breast cancer, offering new diagnostic and therapeutic possibilities.
Exploring the connection between NF1 deficiency, estrogen receptor signaling, and diminished survival rates in breast cancer patients.
Discover how endocrine disrupting chemicals may be hijacking our cellular DNA repair mechanisms through estrogen receptor mediated pathways.